Septic Shock, Pneumonia, Multi-organ Failure (8455163-8)
on Jun 11, 2012 Male patient from SPAIN , 51 years of age, was diagnosed with

• rheumatoid arthritis (rheumatoid arthritis Questions)

and was treated with Chloroquine Phosphate(View Usage). Patient experienced the following unwanted or unexpected effects: septic shock, pneumonia (pneumonia Questions), multi-organ failure. Chloroquine Phosphate dosage: Resochin 50 Comprimidos.
Patient was taking other medications:

• ARAVA (Arava 10 Mg 30 Comprimidos Cubierta Pelicular) (View Arava Review and Arava Label )

Patient was hospitalized.

Toe Amputation, Hypotension, Peripheral Ischaemia, Erythema, Oedema Peripheral, Concomitant Disease Aggravated, Ischaemic Ulcer, Headache, Necrosis (8449361-7)
Patient was taking Chloroquine (View Usage). Patient had the following side effects: toe amputation, hypotension, peripheral ischaemia, erythema, oedema peripheral, concomitant disease aggravated, ischaemic ulcer, headache (headache Questions), necrosis on Jun 07, 2012 from SPAIN Additional patient health information: Female patient , 41 years of age, . Chloroquine dosage: N/A.
Patient was taking other medications:

• TRACLEER (62.5 Mg, Bid) (View Tracleer Review and Tracleer Label )

Cyanosis, Loss Of Consciousness, Oxygen Saturation Decreased, Po2 Increased, Methaemoglobinaemia (8448991-6)
Adverse event was reported on May 29, 2012 by a Male patient taking Chloroquine Diphosphate (View Usage) (Dosage: 1200 Mg; X1; Po) was diagnosed with

• pyrexia

and. Location: INDIA , 25 years of age, After Chloroquine was administered, patient had the following side effects: cyanosis, loss of consciousness, oxygen saturation decreased, po2 increased, methaemoglobinaemia. Patient was hospitalized.

Loss Of Consciousness, Po2 Increased, Methaemoglobinaemia, Cyanosis (8409138-5)
on May 24, 2012 Male patient from INDIA , 25 years of age, was treated with Chloroquine Phosphate (View Usage). Patient experienced the following unwanted or unexpected effects: loss of consciousness, po2 increased, methaemoglobinaemia, cyanosis. Chloroquine Phosphate dosage: N/A. Patient was hospitalized.


Pyrexia, Headache, Heart Rate Increased, Hepatomegaly, Haemolysis, Po2 Increased, Hypoxia, Cerebral Ischaemia, Pulse Pressure Decreased (8385699-X)
on May 17, 2012 Female patient from INDIA , 16 years of age, was diagnosed with

• malaria (malaria Questions)
• environmental exposure

and was treated with Chloroquine Phosphate(View Usage). Patient had the following side effects: pyrexia, headache (headache Questions), heart rate increased, hepatomegaly, haemolysis, po2 increased, hypoxia, cerebral ischaemia, pulse pressure decreased. Chloroquine Phosphate dosage: (df).
Patient was taking other medications:

• ANILINE DYE EXPOSURE ((df)) (View Aniline Dye Exposure Review and Aniline Dye Exposure Label )

Patient was hospitalized.

Ventricular Tachycardia, Toxicity To Various Agents, Ventricular Fibrillation, Pulseless Electrical Activity, Neurotoxicity (8381935-4)
Patient was taking Chloroquine Phosphate (View Usage). After Chloroquine was administered, patient had the following side effects: ventricular tachycardia, toxicity to various agents, ventricular fibrillation, pulseless electrical activity, neurotoxicity on May 11, 2012 from BELGIUM Additional patient health information: Male patient , 24 years of age, . Chloroquine Phosphate dosage: 58 Tablets Of 250 Mg.
Patient was taking other medications:

• DOMPERIDONE (5 Tablets Of 10 Mg) (View Domperidone Review and Domperidone Label )
• ONDANSETRON (10 Tablets Of 4 Mg) (View Ondansetron Review and Ondansetron Label )
• MIDAZOLAM (20 Tablets Of 7.5 Mg) (View Midazolam Review and Midazolam Label )

Pain, Insomnia, Limb Immobilisation, Herpes Virus Infection, Urticaria (8378148-9)
Adverse event was reported on May 17, 2012 by a Female patient taking Chloroquine Phosphate (View Usage) (Dosage: N/A) was diagnosed with

• rheumatoid arthritis (rheumatoid arthritis Questions)

and. Location: MEXICO , weighting 167.6 lb, Patient experienced the following unwanted or unexpected effects: pain (pain Questions), insomnia, limb immobilisation, herpes virus infection, urticaria.
Patient was taking other medications:

• OMEPRAZOLE (View Omeprazole Review and Omeprazole Label )
• METHOTREXATE (View Methotrexate Review and Methotrexate Label )
• CELEBREX (View Celebrex Review and Celebrex Label )
• HUMIRA (View Humira Review and Humira Label )
• FOLIC ACID (View Folic Acid Review and Folic Acid Label )

Herpes Zoster (8276694-X)
on Apr 12, 2012 Male patient from UNITED STATES , 34 years of age, weighting 235.0 lb, was diagnosed with

• malaria prophylaxis

and was treated with Chloroquine Phosphate (View Usage). Patient had the following side effects: herpes zoster. Chloroquine Phosphate dosage: 500 Mg.

Pneumonia, Cardiogenic Shock, Ventricular Fibrillation, Intentional Overdose (8176362-9)
on Feb 22, 2012 Male patient from FRANCE , 53 years of age, was treated with Chloroquine Phosphate(View Usage). After Chloroquine was administered, patient had the following side effects: pneumonia (pneumonia Questions), cardiogenic shock, ventricular fibrillation, intentional overdose. Chloroquine Phosphate dosage: N/A. Patient was hospitalized.

Ventricular Fibrillation, Pneumonia, Cardiogenic Shock, Intentional Overdose, Convulsion (8176336-8)
Patient was taking Chloroquine Phosphate (View Usage). Patient experienced the following unwanted or unexpected effects: ventricular fibrillation, pneumonia (pneumonia Questions), cardiogenic shock, intentional overdose, convulsion on Feb 22, 2012 from FRANCE Additional patient health information: Female patient , 45 years of age, . Chloroquine Phosphate dosage: N/A. Patient was hospitalized.

Toxicity To Various Agents, Respiratory Arrest, Cardiac Arrest (8044947-6)
Adverse event was reported on Dec 27, 2011 by a Female patient taking Chloroquine Phosphate (View Usage) (Dosage: (df Oral)) . Location: UNITED STATES , 82 years of age, Patient had the following side effects: toxicity to various agents, respiratory arrest, cardiac arrest (cardiac arrest Questions).

Arthralgia, Atrioventricular Block Complete, Ventricular Hypertrophy, Myopathy, Ischaemic Cardiomyopathy, Troponin Increased, Coronary Artery Occlusion, Acute Myocardial Infarction, Ejection Fraction Decreased (7981716-7)
on Nov 28, 2011 Female patient from FRANCE , 59 years of age, weighting 88.18 lb, was diagnosed with

• cutaneous lupus erythematosus

and was treated with Chloroquine Phosphate (View Usage). After Chloroquine was administered, patient had the following side effects: arthralgia, atrioventricular block complete, ventricular hypertrophy, myopathy, ischaemic cardiomyopathy, troponin increased, coronary artery occlusion, acute myocardial infarction, ejection fraction decreased. Chloroquine Phosphate dosage: Daily Dose 300 Mg.
Patient was taking other medications:

• PREDNISONE (View Prednisone Review and Prednisone Label )

Constipation, Obstruction Gastric, Abdominal Pain, Abdominal Distension, Gastric Ulcer, Abdominal Discomfort, Weight Decreased (7979556-8)
on Dec 07, 2011 Female patient from LEBANON , 57 years of age, weighting 167.6 lb, was treated with Chloroquine Phosphate(View Usage). Patient experienced the following unwanted or unexpected effects: constipation (constipation Questions), obstruction gastric, abdominal pain (abdominal pain Questions), abdominal distension, gastric ulcer, abdominal discomfort, weight decreased. Chloroquine Phosphate dosage: N/A.
Patient was taking other medications:

• METHOTREXATE (View Methotrexate Review and Methotrexate Label )
• PPI (View Ppi Review and Ppi Label )
• NSAID'S (View Nsaid's Review and Nsaid's Label )
• HUMIRA (View Humira Review and Humira Label )
• PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label )

Patient was hospitalized.

Hypoalbuminaemia, Disseminated Intravascular Coagulation, Pneumonia, Anaemia, Sepsis (7917803-9)
Patient was taking Chloroquine Diphosphate (View Usage). Patient had the following side effects: hypoalbuminaemia, disseminated intravascular coagulation, pneumonia (pneumonia Questions), anaemia, sepsis (sepsis Questions) on Sep 28, 2011 from INDONESIA Additional patient health information: Female patient , weighting 112.4 lb, . Chloroquine Diphosphate dosage: N/A.
Patient was taking other medications:

• CALCIUM PHOSPHATE, DIBASIC (View Calcium Phosphate, Dibasic Review and Calcium Phosphate, Dibasic Label )
• ACTEMRA (Last Dose Prior To Sae: 04 August 2011, Permanently Discontinued) (View Actemra Review and Actemra Label )
• FOLIC ACID (View Folic Acid Review and Folic Acid Label )
• METHOTREXATE (View Methotrexate Review and Methotrexate Label )
• PREDNISONE (View Prednisone Review and Prednisone Label )
• OMEPRAZOLE (View Omeprazole Review and Omeprazole Label )

Patient was hospitalized.

Cervix Carcinoma, Vaginal Haemorrhage, Weight Decreased, Visual Acuity Reduced, Vision Blurred, Diarrhoea, Nausea (7898506-6)
Adverse event was reported on Oct 26, 2011 by a Female patient taking Chloroquine Diphosphate (View Usage) (Dosage: N/A) . Location: MEXICO , 69 years of age, weighting 105.8 lb, After Chloroquine was administered, patient had the following side effects: cervix carcinoma, vaginal haemorrhage, weight decreased, visual acuity reduced, vision blurred, diarrhoea, nausea (nausea Questions).
Patient was taking other medications:

• SULINDAC (View Sulindac Review and Sulindac Label )
• ARAVA (View Arava Review and Arava Label )

Patient was hospitalized.

Liver Function Test Abnormal (7833866-3)
on Oct 19, 2011 Female patient from MEXICO , 68 years of age, weighting 114.6 lb, was diagnosed with

• rheumatoid arthritis (rheumatoid arthritis Questions)
• herpes zoster
• hypothyroidism

and was treated with Chloroquine Diphosphate (View Usage). Patient experienced the following unwanted or unexpected effects: liver function test abnormal. Chloroquine Diphosphate dosage: N/A.
Patient was taking other medications:

• CHLORHYDRATE TRAMADOL SOLYMES (View Chlorhydrate Tramadol Solymes Review and Chlorhydrate Tramadol Solymes Label )
• LEVOTHYROXINE SODIUM (Dose And Daily Dose: 3/4 Tablet Of 100 Mcg) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label )
• HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label )
• FOLIC ACID (View Folic Acid Review and Folic Acid Label )
• ARAVA (View Arava Review and Arava Label )
• METHOTREXATE (View Methotrexate Review and Methotrexate Label )

Nausea, Feeling Abnormal, Decreased Appetite, Weight Decreased (7817090-6)
on Oct 14, 2011 Female patient from UNITED STATES , 71 years of age, weighting 150.0 lb, was diagnosed with

• malaria prophylaxis

and was treated with Chloroquine Diphosphate(View Usage). Patient had the following side effects: nausea (nausea Questions), feeling abnormal, decreased appetite, weight decreased. Chloroquine Diphosphate dosage: 500mg 1 Per Week Oral.

Pyrexia, Malaise, Weight Decreased, Hepatic Enzyme Increased (7817048-7)
Patient was taking Chloroquine Diphosphate (View Usage). After Chloroquine was administered, patient had the following side effects: pyrexia, malaise, weight decreased, hepatic enzyme increased on Oct 14, 2011 from UNITED STATES Additional patient health information: Male patient , 71 years of age, weighting 175.0 lb, was diagnosed with

• malaria prophylaxis

and. Chloroquine Diphosphate dosage: 500 Mg 1 Per Week Oral. Patient was hospitalized.

Torsade De Pointes, Overdose, Sinus Tachycardia, Electrocardiogram Qrs Complex Prolonged, Cardiac Arrest, Suicide Attempt, Hypokalaemia, Blood Pressure Decreased (7759770-7)
Adverse event was reported on Sep 14, 2011 by a Female patient taking Chloroquine Phosphate (View Usage) (Dosage: 25 Df, Unk) . Location: HONG KONG , 37 years of age, Patient experienced the following unwanted or unexpected effects: torsade de pointes, overdose, sinus tachycardia, electrocardiogram qrs complex prolonged, cardiac arrest (cardiac arrest Questions), suicide attempt, hypokalaemia, blood pressure decreased.
Patient was taking other medications:

• HYDROXYCHLOROQUINE SULFATE (30 Df, Unk) (View Hydroxychloroquine Sulfate Review and Hydroxychloroquine Sulfate Label )

Patient was hospitalized.

Shock, Torsade De Pointes, Electrocardiogram Qrs Complex Prolonged, Intentional Overdose, Coma, Sinus Tachycardia, Cardiac Arrest, Completed Suicide, Hypotension (7757748-0)
on Sep 05, 2011 Female patient from HONG KONG , 37 years of age, was diagnosed with

• overdose

and was treated with Chloroquine (View Usage). Patient had the following side effects: shock, torsade de pointes, electrocardiogram qrs complex prolonged, intentional overdose, coma, sinus tachycardia, cardiac arrest (cardiac arrest Questions), completed suicide, hypotension. Chloroquine dosage: 25 Tablets Of Chloroquine 250mg.
Patient was taking other medications:

• HYDROXYCHLOROQUINE SULFATE (30 Tablets Of Hydroxychloroquine 200mg) (View Hydroxychloroquine Sulfate Review and Hydroxychloroquine Sulfate Label )

Sinus Tachycardia, Cardiac Arrest, Suicide Attempt, Electrocardiogram Qrs Complex Prolonged, Torsade De Pointes, Blood Pressure Decreased, Hypokalaemia, Overdose (7753385-2)
on Sep 12, 2011 Female patient from HONG KONG , 37 years of age, was treated with Chloroquine Phosphate(View Usage). After Chloroquine was administered, patient had the following side effects: sinus tachycardia, cardiac arrest (cardiac arrest Questions), suicide attempt, electrocardiogram qrs complex prolonged, torsade de pointes, blood pressure decreased, hypokalaemia, overdose. Chloroquine Phosphate dosage: 25 Df, Unk.
Patient was taking other medications:

• HYDROXYCHLOROQUINE (30 Df, Unk) (View Hydroxychloroquine Review and Hydroxychloroquine Label )

Patient was hospitalized.

Overdose, Cardiac Arrest, Agitation, Torsade De Pointes, Restlessness, Loss Of Consciousness, Pulse Absent, Pneumonia (7657436-5)
Patient was taking Chloroquine Phosphate (View Usage). Patient experienced the following unwanted or unexpected effects: overdose, cardiac arrest (cardiac arrest Questions), agitation, torsade de pointes, restlessness, loss of consciousness, pulse absent, pneumonia (pneumonia Questions) on Jul 29, 2011 from SINGAPORE Additional patient health information: Female patient , 37 years of age, was diagnosed with

• suicide attempt
• depression (depression Questions)

and. Chloroquine Phosphate dosage: N/A.
Patient was taking other medications:

• FLUVOXAMINE MALEATE (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label )
• ZOLPIDEM (View Zolpidem Review and Zolpidem Label )
• NAPROXEN (View Naproxen Review and Naproxen Label )

Patient was hospitalized.

Aggression, Confusional State (7590169-2)
Adverse event was reported on Jun 21, 2011 by a Male patient taking Chloroquine (watson Laboratories) (View Usage) (Dosage: N/A) . Location: FRANCE , 53 years of age, Patient had the following side effects: aggression, confusional state.
Patient was taking other medications:

• PROGUANIL (View Proguanil Review and Proguanil Label )

Dysaesthesia, Polyneuropathy, Paraesthesia, Hyporeflexia, Asthenia (7488880-7)
on May 10, 2011 Female patient from MEXICO , 48 years of age, was diagnosed with

• rheumatoid arthritis (rheumatoid arthritis Questions)

and was treated with Chloroquine (View Usage). After Chloroquine was administered, patient had the following side effects: dysaesthesia, polyneuropathy, paraesthesia, hyporeflexia, asthenia. Chloroquine dosage: 150 Mg, Qd.
Patient was taking other medications:

• GLYBURIDE (5 Mg, Bid) (View Glyburide Review and Glyburide Label )
• PREDNISONE (7.5 Mg, Qd) (View Prednisone Review and Prednisone Label )
• LEFLUNOMIDE (100 Mg, Qd For Three Days) (View Leflunomide Review and Leflunomide Label )

Diverticulitis, Discomfort, Flatulence, Abdominal Pain (7477609-4)
on May 02, 2011 Female patient from BRAZIL , 71 years of age, weighting 172.0 lb, was diagnosed with

• osteoarthritis (osteoarthritis Questions)
• memory impairment
• gastrooesophageal reflux disease

and was treated with Chloroquine Diphosphate(View Usage). Patient experienced the following unwanted or unexpected effects: diverticulitis, discomfort, flatulence, abdominal pain (abdominal pain Questions). Chloroquine Diphosphate dosage: N/A.
Patient was taking other medications:

• PIRACETAM (View Piracetam Review and Piracetam Label )
• MOTILIUM (View Motilium Review and Motilium Label )
• CIMETIDINE (View Cimetidine Review and Cimetidine Label )
• ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label )
• MYLICON GOTAS (View Mylicon Gotas Review and Mylicon Gotas Label )
• CASCARA SAGRADA (View Cascara Sagrada Review and Cascara Sagrada Label )
• DIACEREIN (View Diacerein Review and Diacerein Label )
• MELOXICAM (View Meloxicam Review and Meloxicam Label )